Cancer agency OK'd faulty $11M grant

by Paul J. Weber

(AP)—Texas' embattled $3 billion cancer-fighting agency approved an $11 million grant to a biomedical company even though the proposal wasn't reviewed.

A person with knowledge of the discovery tells The Associated Press the improper funding was uncovered during an internal audit of the and Research Institute of Texas.

The grant in 2010 to Dallas-based Peloton Therapeutics Inc. was among the agency's first.

The person told AP Peloton's funding has been halted and its application is being reviewed. The person spoke on condition of anonymity because the agency hasn't announced the audit's findings.

The agency is home to the second largest of cancer-research dollars. It came under scrutiny after several scientists, including Nobel laureates, resigned claiming it was charting a new politically-driven path putting commercial interests before .

not rated yet
add to favorites email to friend print save as pdf

Related Stories

School leader resigns over science memo

Nov 30, 2007

The head of the Texas Education Agency's science curriculum alleges she was forced to resign because of a memo about a talk on intelligent design.

Global Fund announces new anti-corruption measures

Feb 04, 2011

(AP) -- A $21.7 billion global health fund and the U.N.'s main development arm launched new anti-corruption measures Friday in the wake of intense scrutiny from donors and stories by The Associated Press detailing fraud ...

KKR, Silver Lake near deal on Go Daddy

Jun 24, 2011

(AP) -- Go Daddy, the domain-name registration company known for its racy Super Bowl ads, is close to being bought by two private investment firms for up to $2.5 billion, according to a person close to the deal.

Nobel history illustrates gap in grants to young scientists

Jan 10, 2012

A new study by Rice University's Baker Institute for Public Policy illustrates a disconnect between government funding of biomedical research by young investigators and a novel standard by which to judge it: the Nobel Prize.

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.